Note 8 - Notes and Loans Payable (Details) (USD $)	3 Months Ended	12 Months Ended	45 Months Ended													1 Months Ended			1 Months Ended			3 Months Ended	12 Months Ended	33 Months Ended	3 Months Ended		1 Months Ended	3 Months Ended
	Mar. 31, 2014	Dec. 31, 2013	Mar. 31, 2014	Feb. 24, 2014	Jul. 31, 2013	May 31, 2013	Apr. 30, 2014 Subsequent Event [Member] Mablife [Member] Patents [Member]	Feb. 28, 2014 Subsequent Event [Member] Mablife [Member] Patents [Member]	Feb. 28, 2014 Subsequent Event [Member] Mablife [Member] February 2014 [Member] Patents [Member]	Feb. 28, 2014 Subsequent Event [Member] Mablife [Member] April 2014 [Member] Patents [Member]	Feb. 28, 2014 Subsequent Event [Member] Mablife [Member] May 2014 [Member] Patents [Member]	Feb. 28, 2014 Subsequent Event [Member] Mablife [Member] June 2014 [Member] Patents [Member]	Feb. 28, 2014 Subsequent Event [Member] Mablife [Member] August 2014 [Member] Patents [Member]	Aug. 31, 2013 Tranche 2 [Member] Midcap [Member]	Aug. 31, 2013 Tranche 1 and 2 [Member] Midcap [Member]	Mar. 31, 2014 Fourth Amendment [Member]	Mar. 31, 2012 Mablife [Member]	Aug. 31, 2013 Midcap [Member]	Apr. 30, 2014 Mablife [Member] Patents [Member]	Feb. 28, 2014 Mablife [Member] Patents [Member]	Apr. 30, 2012 Mablife [Member] Patents [Member]	Mar. 31, 2014 Mablife [Member] Patents [Member]	Dec. 31, 2013 Mablife [Member] Patents [Member]	Mar. 31, 2014 Mablife [Member] Patents [Member]	Mar. 31, 2014 Mablife [Member] Secondary Patent Rights [Member]	Feb. 28, 2014 Mablife [Member] Secondary Patent Rights [Member]	Mar. 31, 2014 Term Loan [Member] Patents [Member]	Mar. 31, 2014 Term Loan [Member]	Feb. 28, 2014 Term Loan [Member]	Jul. 31, 2013 Line of Credit [Member]
Note 8 - Notes and Loans Payable (Details) [Line Items]
Loans Payable																		$ 4,442,000
Debtor-in-Possession Financing, Unused Borrowings														1,000,000
Debt Instrument, Term Loan, Principal Payment Requirements, Net Cash Proceeds														17,500,000
Debt Instrument, Interest Rate, Stated Percentage						10.00%									11.50%		12.00%												7.10%	6.10%
Class of Warrant or Right, Number of Securities Called by Warrants or Rights (in Shares)						500,000								101,531
Class of Warrant or Right, Exercise Price of Warrants or Rights (in Dollars per Item)				5.04										3.50
Warrants and Rights Outstanding														300,000
Debt Instrument, Periodic Payment																135,000											16,000
Line of Credit Facility, Maximum Borrowing Capacity	5,000,000		5,000,000		37,000
Debt Instrument, Face Amount						50,000																							156,000
Class of Warrant or Right, Percent Discount Off Exercise Price Per Share						10.00%
Interest Expense, Debt		50,000																										4,000
Notes Payable																	600,000
Notes Payable, Fair Value Disclosure																	376,000
Royalty Rate, Percent of Net Sales																	0.60%
Purchase Obligation, Future Minimum Payments, Remainder of Fiscal Year							100,000		20,000	35,000	80,000	33,000	34,000
Purchase Obligation, Due in Second Year							100,000	25,000																		25,000
Purchase Obligation, Due in Third Year							100,000	25,000																		25,000
Purchase Obligation, Due in Fourth Year								25,000												35,000						25,000
Purchase Obligation, Due in Fifth Year								25																		35,000
Repayments of Debt																			35,000	20,000	60,000
Amortization of Debt Discount (Premium)	90,000		90,000																			11,000	12,000	169	1,000
Purchase Obligation																										150,000
Purchase Obligation, Due in Next Twelve Months																										25,000
Obligations, Fair Value Disclosure																										$ 112,000